The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
https://screen4.org/product/visitect-rapid-finger-prick-antibody-test/
I think it will be hard to buy at those levels without an RNS
That is brilliant news for the world if it becomes matter of a fact. Right, what vitamin company are we investing in?
It wasn't me to be fair haha. My mate text me it whilst I was in a meeting and I had to remain composed.
For professional use at the moment.
https://screen4.org/product/visitect-rapid-finger-prick-antibody-test/
It is the Mologic one dummy
Previous RNS already game a timescale for commercial sales.
The placing was during COVID. Likely be a placing around approval but by that point the share price, I think will be much higher.
Fair enough. I look forward to your positive commentary on your investment.
"If need be" for your own personal agenda.
Glad you agree
MIKODX, I think your narrative changed when you posted this...
Took a nice big slice of the cake today. At 400% markup it would have been stupid not to. Lots are selling off and if it continues like this I can see the SP dropping further, so decided to cash some in before it does. ODX only have themselves to blame, if you put a time on something and don't deliver, you will scare investors off.
1. They respond to comments made about selling 2. Some say that they have sold out and start a negative campaign on the boards or twitter creating uncertainty and panic in an attempt to make investors panic sell.
The last placing was to take right up to approval. I reckon there will be a steady climb right up to the hype that will start before lift off.
It is good to debate however I can't stand it when someone sells and their whole narrative changes and they linger about the boards making negative comments. Buy back in or find another investment. Try not to look at the share price in the coming months though as this will be the one that got away.
I agree recently that there was a pump and dump on VAL however tests appear to have stopped progression in Terminal Prostate Cancer in 54% of patients. Very early doors though and needs more rigorous testing.
The last placing was to cover expansion to 2 million tests per week. Any further expansion should be funded by sales.
Ouch tcxman. That must have hurt.
Bloody meetings! Good you are still in a bit of profit. I feel for those that invested at 60ish. VAL201 looks promising.